News

Orbit International Secures $1.5M in New Power Contracts

Orbit International Secures $1.5M in New Power Contracts

Orbit International's Recent Achievements

Orbit International Corp. (OTCID Basic Market:ORBT), headquartered in Hauppauge, N.Y., is making waves in the electronics manufacturing industry. Recently, its Power Group (OPG) has achieved significant contract awards totaling approximately $1,500,000. This robust activity highlights Orbit International's commitment to delivering advanced solutions for military and commercial applications.

Details of the Contract Awards

Breaking Down the Contracts

The two new awards include a follow-on contract for a Commercial Off-The-Shelf (COTS) power supply specifically used within a military program, along with an award for a VPX power supply. This move indicates not only an increase in orders but also a reliable stream of work that is expected to advance through the calendar year.

Expected Timeline and Delivery

Deliveries for these significant contracts are projected to commence in the second quarter of 2026, continuing through to the fourth quarter of that year. This timeline indicates a clear pathway for operational expansion within the Power Group.

Comments from Leadership

Mitchell Binder, President and CEO of Orbit International, shared his optimism regarding the company's current trajectory. He stated, "Our OPG continued its strong bookings in the current quarter with two orders totaling approximately $1,500,000. These recent additions follow more than $1,700,000 in bookings received in August alone. One award is associated with a critical military program for the U.S. Navy, while the other complements our advanced VPX power solutions. This ongoing demand showcases our industry leadership and responsiveness to military needs."

Future Opportunities

In addition to the ongoing successes within the Power Group, Binder noted that the Orbit Instrument division and Simulator Product Solutions LLC are pursuing a variety of new and follow-on business prospects. An anticipated award is especially promising, linked to longstanding collaborations with the U.S. Navy. Although the exact timelines remain uncertain, the potential for additional orders from these sectors is strong.

About Orbit International Corp.

Orbit International is deeply involved in crafting and manufacturing specialized electronic devices and subsystem solutions. Their contributions span military, industrial, and commercial use cases, with production facilities located in Hauppauge, New York, and Carson, California. The Power Group within Orbit focuses on designing and delivering an extensive range of power products, such as VPX, COTS, and commercial power supplies. This strategic positioning allows Orbit International to remain at the forefront of electronic innovation.

Frequently Asked Questions

What is the significance of the recent contract awards for Orbit International?

The contract awards, totaling $1.5 million, signify a strong demand for Orbit's power solutions and highlight its position as a key supplier for military programs.

When will deliveries for these new contracts start?

Deliveries for the awarded contracts are expected to start in the second quarter of 2026 and will continue until the fourth quarter of the same year.

What types of power products does Orbit International manufacture?

Orbit manufactures a wide array of power products, including VPX and COTS power supplies designed for various military and commercial applications.

How does Orbit plan to maintain its order flow in the future?

Orbit plans to pursue additional awards through its divisions and continues to engage in bidding for new opportunities, primarily within military sectors.

Who can be contacted for more information about Orbit International?

For further inquiries, David Goldman, the Chief Financial Officer, can be reached at 631-435-8300.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 584

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Laboratoires Pierre Fabre and XtalPi Unite for AI-Driven Drug Hunt

Updated Category News Views 128

An Unexpected Turn in the Drug Discovery Arena It's not every day that you see a historic French pharma powerhouse and a cutting-edge Chinese tech firm join forces. On one side, we've got Laboratoires Pierre Fabre, steeped in the history and nitty-gritty of clinical drug development. On the other, we’ve got XtalPi Holdings Limited (2228.HK), bringing their high-tech AI...

Continue Reading
Strathcona Resources Q3 2026: Dividends, Deals, and Growth

Updated Category News Views 207

Digging into Strathcona's Third Quarter Strathcona Resources (TSX: SCR) is strutting its stuff again, dropping a third-quarter report that reads like a playbook for solid energy sector performance. First off, let’s talk about that dividend bump. The company decided to sprinkle some cheer with a 7% increase in its quarterly dividend, now at $0.32 per share. Not exactly...

Continue Reading
Tencent Cloud's Edge Platform Shines in New Gartner Report

Updated Category News Views 114

The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 353

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Telespazio & Rivada Forge Secure Satellite Network

Updated Category News Views 61

Rivada's Outernet: A New Era of Connectivity Forget the terrestrial wires; we're talking about 600 satellites playing a space-age game of telephone. That's Rivada's Outernet for you, an orbital mesh network that's about to upend the very nature of global communications. Telespazio's new partnership with Rivada is like strapping a rocket onto secure connectivity in the...

Continue Reading
PharmaBlock Forum: Strategic CMC Moves Crucial for Biotech

Updated Category News Views 83

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

Continue Reading
AI Tool Identifies PTSD in ER: Game-changer?

Updated Category News Views 18

Pushing Boundaries: AI and Emergency Room Narratives When you think about the chaos of an emergency room, PTSD might not be the first thing that comes to mind. But for the folks developing cutting-edge AI at NYU Langone Health, it's a crucial window of opportunity. Enter PREVIA, an AI tool that’s been tapping into patients’ narratives to pinpoint PTSD risks with...

Continue Reading
EICMA 2026: Groundbreaking Moves in Two-Wheel World

Updated Category News Views 9

Revving Up in Milan: A Record-Breaking EICMA If you're into two-wheelers as much as stocks, EICMA 2026 is where all the action is happening. They opened the door with a bang at Fiera Milano Rho, pulling off their biggest showcase yet. Ten halls packed to the brim, up from nine the previous year, creating buzz across the globe. Showcasing 765 exhibitors and 2,142 brands...

Continue Reading
Nutex Health Scores Top Workplace Honor in 2026

Updated Category News Views 43

Nutex Health: Accolades and Aspirations Nutex Health just snagged something pretty noteworthy: They've been crowned a 2026 Houston Top Workplace by the Houston Chronicle. Now, before you start throwing confetti, let's chew on what this really means. It's no small potatoes, folks. We're talking employee respect and satisfaction measured by Energage’s surveys. It's proof...

Continue Reading

Top 5 Most Recently Viewed Articles

Orla Mining's Earnings Predictions and Market Insights

Updated Category News Views 537

Anticipated Earnings Release for Orla Mining Orla Mining (AMEX: ORLA) is set to unveil its quarterly earnings, and investors are keenly observing the upcoming report. Analysts are projecting the company will announce an earnings per share (EPS) of $0.20, which generates a mix of anticipation and excitement in the market. Insights Into Previous Earnings Performance In the...

Continue Reading
Bar Leone Reigns Supreme as Asia's Best Bar Again

Updated Category News Views 209

Bar Leone Recognized as Asia's Leading Bar for Two Years Bar Leone has once again captured the prestigious title of The Best Bar in Asia, an accolade it earned for the second consecutive year at the Asia's 50 Best Bars ceremony. This recognition, sponsored by Perrier, marks a significant milestone in the vibrant cocktail culture across the continent. Outstanding...

Continue Reading
Commvault Faces Securities Fraud Lawsuit: What's Next?

Updated Category News Views 36

Unpacking Commvault's Legal Headaches There's fresh trouble brewing in the world of Commvault Systems Inc. (NASDAQ: CVLT). Investors licking their wounds have a chance to rally in a securities fraud class action lawsuit. It all circles back to some allegedly shady moves—or, more precisely, what the company didn't spill between April 2025 and January 2026. The Crux of...

Continue Reading
Investigating Lumos Pharma's Acquisition: Implications for Shareholders

Updated Category News Views 76

Investigation into Lumos Pharma's Proposed Acquisition Rowley Law PLLC is currently looking into potential securities law violations related to Lumos Pharma, Inc. (NASDAQ: LUMO). This investigation centers around the proposed acquisition of Lumos Pharma by Double Point Ventures LLC. Under the terms of this acquisition, shareholders are set to receive $4.25 along with one...

Continue Reading
LKQ Faces Investor Suit: Key Impacts & Deadlines

Updated Category News Views 17

LKQ's Acquisition Missteps Ignite Investor Action Just when you think you've seen it all in the stock market, something like this drops—another punch in the gut reminding us that no company is impervious to stumbling. LKQ Corporation (NASDAQ: LKQ) has got itself tangled in some messy legal affairs, thanks to a string of ugly truths coming to light from its pricey $2.1...

Continue Reading